Suchen und Finden
Preface
4
Contents
6
Contributors
8
Part I Management of
10
1 Live Donors of Tissue
11
The Process of Making a Living Donation
11
Circumstances of Living Donation: How Are Tissues from Live Donors Obtained?
16
Femoral Head Donation
16
Amniotic Membrane Donation
18
Limbal Stem Cell Donation
18
Cord Blood Donation
19
Donor Selection: Evidence Base and General Considerations
20
Exclusion of Living Donors of Bone
21
Other Examples of Selection of Living Tissue Donors to Reduce Risk of Disease Transmission
22
Males Who Have Had Sex with Males (MSM)
23
Selection of Cord Blood Donors
24
Microbiological Screening of the Mother and Cord
24
HIV and Hepatitis B and C
24
Other Types of Potential Disease Transmission by Cord Blood
25
Genetic Disease
26
Travel History
26
Bacterial Risk
26
References
26
2 Deceased Donors of Tissue
30
Introduction
30
Tissue Donor Detection
33
Tissue Donor Selection and Evaluation
36
Review Donor's Medical History
38
General Donor Exclusion Criteria
38
Tissue Absolute Contraindication and Age Criteria
39
Heart Valves
40
Vascular
40
Skin
40
Musculoskeletal
41
Eye Tissues
41
Family Consent Details and Donor's Social History
41
Donor's Physical Examination
44
Blood Sample Collection
44
Biopsy/Autopsy Results
46
Conclusion
46
References
46
3 Banking of Cord Blood
48
Introduction
48
Cord Blood Collection and Banking
50
Cord Blood Banks Development
50
Unrelated Cord Blood Banks
51
Sibling Donor Cord Blood Banks
54
Autologous Cord Blood Banks
55
Netcord Organization: Standards and Guidelines
56
Description of Existing Guidelines
57
Practical Aspects of Cord Blood Banking
57
Informed Consent
57
Collection Techniques
57
Infectious Disease Testing
58
Genetic Disease Testing
58
HLA Typing
58
Cell Processing
58
Cryopreservation and Storage
59
Ethical and Legal Aspects
60
Clinical Experience with Related and Unrelated Umbilical Cord Blood Transplantation
61
Clinical Results of Cord Blood Transplantation from Eurocord Registry
62
Influence of Cell Dose and HLA on Transplantation Outcome
62
Conclusion
64
References
64
4 Banking of Corneas
66
Eye Donation
66
Corneal Transplantation
67
Corneal Storage
69
Hypothermia
69
Organ Culture
70
Limbal Stem Cells
72
References
73
5 Banking of Heart Valves
75
Introduction
75
Selection Criteria
75
Processing and Disinfection of Heart Valves
76
Quality Assurance of Heart Valves
79
Current Issues in Heart Valve Banking
80
Viability and Storage
80
Endothelial Cells
81
Morphology of the Valves
82
Mechanical Properties of Valves
82
Conclusions
83
References
84
6 Banking of Skin
87
Acquisition
89
Retrieval
89
Preservation and Storage
95
Conclusions
97
References
98
Part II Principles of
99
7 Storage, Processing and Preservation
100
Introduction
100
Tissue Replacement
100
Autologous Versus Allogeneic Grafts
101
Immunological Reponses to Tissue Allografts
101
Principles of Tissue Preservation
103
Preservation of Non Viable Tissue Grafts
103
Causes of Degradation
103
Reduction of Water Activity
104
Cell Removal
106
Preservation of Viable Tissue Grafts
106
Principles of Disinfection and Sterilisation
107
Definitions
107
Disinfection Methods
109
Viable Tissues
109
Non-viable Tissues
110
Sterilisation Methods
110
Physical Methods
110
Chemical Methods
111
References
111
8 Cryopreservation
113
Introduction
113
Tissues that Do Not Require Living Cells for Effectiveness
114
Tissues that May Not Require Living Cells
115
Tissues that Do Require Living Cells
115
Cryopreservation
116
Cryopreservation of Multicellular Systems
119
Cryopreservation by Vitrification
122
Conclusions
123
References
124
9 Sterilisation by Irradiation
126
Introduction
126
Specificity of Radiation Sterilisation with Gamma Rays and Electron Beams
128
Dosimetry for Radiation Sterilisation
131
Mechanisms Involved in the Inactivation of Micro-Organisms by Ionising Radiation
136
Radiation Resistance of Micro-Organisms
136
Factors Affecting the Effectiveness of Radiation Sterilisation and the Sensitivity of Micro-Organisms to Irradiation
139
References
140
Part III Ensuring Safety by
142
10 Testing the Donor
143
Introduction
143
Range of Infectious Agents
144
Mandatory Screening
147
Discretionary Screening
149
Other Screening
149
Severe Acute Respiratory Syndrome (SARS)
151
Chikungunya
152
Lymphochoriomeningitis Virus (LCMV)
152
Leishmania
153
Screening Strategy
153
Sample Quality
156
Samples from Living Tissue Donors
156
Samples from Cadaveric (Non Heart-Beating) Donors
156
Screening
159
Serological Screening
160
Molecular Screening
161
Residual Risk
163
Window Period
164
Conclusions
165
References
166
11 Testing the Tissue and the Environment
168
Introduction
168
Microbal Testing of Tissues Recovered Prior to Processing
170
Testing Tissue from Deceased Donors
170
Testing of Tissue from Living Donors
171
Postmortem Blood Cultures
172
Environmental Monitoring of Cleanrooms Used for Tissue Processing
172
Cleanroom Classification
173
Sampling of Cleanroom Air for Viable Particulates
174
Passive Air Sampling: Settling Plates
174
Active Air Sampling
174
Sampling of Cleanroom Surfaces for Microbes: Contact Plates
175
Sampling of Cleanroom Surfaces for Microbes: Swabbing
175
Sampling Locations
175
Sampling Timing
176
Trend Analysis and Action Levels
176
Final Microbial Testing of Allografts After Processing
176
Final Allograft Testing
176
Sampling Methods -- Swab Sampling
177
Swab Efficiency Validation
179
Sampling Methods -- Whole Allograft Immersion and Extraction (Bioburden Testing)
181
Sampling Methods -- Destructive Testing
181
Bacteriostasis/Fungistasis (B/F) Testing
182
Final Testing of Sterilized Allografts
182
Process Validation and Sterility Assurance
183
Process Control Testing In Lieu Of Final Tissue Testing
184
Microbial Testing of the Tissue Allograft Immediately Prior to Implantation
184
Summary
185
References
185
Part IV Ensuring Quality by
189
12 Establishing a Quality System
190
Quality Tools
191
A Sequential, Historical Perspective -- Standards and Regulations
193
Significant Quality Projects
202
Practical Applications of QMS and QC for Tissue Establishments
204
General Quality Management Responsibilities
205
Considerations for a Tissue Establishment's QMS
206
Examples of Third-Party Agreements (Written Contracts or Other Arrangements)
206
Tissue Establishment Functions or Practices That Could Be QC'ed (Written Procedures Required for All Functions)
207
Examples of Tissue Establishment QC Programs
207
Measuring Assurance and Expectations
209
Determining Critical Points of Tissue or Cell Processing
209
Future Considerations
211
Conclusion
211
A Note from the Author
212
References
212
13 IT System
215
What Are the Operational Requirements?
215
Why Use an IT System?
216
The Benefits of an IT System
217
Developing the Operational Requirements Document (ORD)
218
Technology Solutions
218
Barcodes
219
Linear Bar Codes
219
2-Dimensional Bar Codes
219
Radio Frequency Identification (RFID)
219
Electronic Data Interchange (EDI)
220
Database Management Technology
220
Selecting an IT System
220
Cost of an IT System
221
Implementing an IT System
222
Money and People
223
Physical Implementation
224
System Validation
224
User Training
224
Managing an IT System
225
Conclusions
225
References
226
Part V Legal and Ethical Environment
227
14 Regulatory and Ethical Issues
228
Introduction
228
Ethical Uses of Human Tissues: Transplantation and Transfusion
229
The Crucial Nature of Consent
229
The Question of Ownership
230
Living donors
231
Consent to Donation
231
Consent to Use
231
Consent to the Consequences of Donation
232
Withdrawal of Consent
232
Deceased Donors
233
Disposal of Tissue Obtained from Deceased Donors
234
The Passage of Information Between Recipient and Donor
234
The Law
235
Presumed Consent
237
References
238
Index
239
Alle Preise verstehen sich inklusive der gesetzlichen MwSt.